Our Technologies
At Cyclomics, we are pioneering advancements in molecular diagnostics with our flagship technology, CyclomicsSeq. This cutting-edge liquid biopsy and consensus sequencing platform enables highly sensitive detection of genetic mutations and cancer biomarkers from blood samples. Leveraging our deep expertise in molecular biology and sequencing, we have developed a suite of innovative technologies that offer robust solutions for plasmid sequencing, methylation analysis, and DNA barcoding.
Our commitment to excellence in research and development drives us to continually push the boundaries of what is possible in genomic science, delivering transformative solutions for healthcare and beyond. Find out more about our technology portfolio.
Can we help with your project?
Let's have a chat!
At Cyclomics, we provide cutting-edge sequencing solutions powered by our proprietary technologies, including CyclomicsSeq and NanoRCS. Our expertise in Nanopore sequencing enables us to deliver high-precision results for a wide range of applications, from early cancer detection to comprehensive genetic analysis. In addition to our specialized assays, we offer tailored Contract Research Organization (CRO) services, allowing you to benefit from our advanced technology and deep industry knowledge. Explore our solutions and discover how Cyclomics can help accelerate your research and development.